GPR87 promotes DMBA/TPA-induced skin tumorigenesis through the YAP–SOX2 axis
Carcinogenesis · 2026
DOI: 10.1093/carcin/bgag065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2026. Verfasst von Biao Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China. Hauptthemen laut MEDLINE: SOXB1 Transcription Factors, Skin Neoplasms, Carcinogenesis, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
G protein-coupled receptor 87 (GPR87) has been implicated in the growth and progression of several malignancies, but its role in cutaneous squamous cell carcinoma (cSCC) remains poorly understood. Here, we found that GPR87 was aberrantly upregulated in murine and human skin tumors and in 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated HaCaT keratinocytes. Using a 7,12-dimethylbenz[a]anthracene (DMBA)/TPA-induced mouse skin tumor model, we demonstrated that GPR87 knockout significantly delayed epidermal hyperplasia, tumor initiation, and malignant progression. Consistently, GPR87 knockdown suppresses TPA-induced keratinocyte proliferation, migration, stemness, and epithelial–mesenchymal transition in keratinocytes and cSCC cells. Mechanistically, GPR87 deficiency markedly reduced SOX2 expression in cultured cells and skin lesions. GPR87 knockdown also enhanced mammalian STE20-like serine/threonine kinases 1/2 (MST1/2) and large tumor suppressor kinases (LATS1/2) phosphorylation, increased inhibitory YAP phosphorylation, and suppressed Yes-associated protein (YAP) nuclear localization and downstream transcriptional activity. Importantly, activation of YAP by either YAP(S127A) expression or XMU-MP-1 treatment restored SOX2 expression in GPR87-depleted cells, whereas verteporfin-mediated inhibition of YAP–TEA domain transcription factor (TEAD) activity attenuated TPA-induced SOX2 upregulation. Together, these findings identify GPR87 as a key positive regulator of skin tumor initiation and progression and demonstrate that its tumor-promoting effects are mediated, at least in part, through the YAP–SOX2 axis. GPR87 may therefore represent a potential therapeutic target for cSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.
- Department of Dermatology, Yangzhi Rehabilitation Hospital, Tongji University, Shanghai 201619, China.
- Liwa Institute of Skin Health, East China Normal University, Shanghai 200241, China.
ORCID-Profile: Biao Guo, Xiaofeng Qin, Jiahui Yu, Yijing Ma, Yongyan Dang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, B., Liang, Y., Qin, X., Yang, Z., Yu, J., Liu, R., Ma, Y., Zheng, Q., Ye, X., & Dang, Y. (2026). GPR87 promotes DMBA/TPA-induced skin tumorigenesis through the YAP–SOX2 axis. Carcinogenesis. https://doi.org/10.1093/carcin/bgag065
Vancouver
Guo B, Liang Y, Qin X, Yang Z, Yu J, Liu R, et al. GPR87 promotes DMBA/TPA-induced skin tumorigenesis through the YAP–SOX2 axis. Carcinogenesis. 2026. doi:10.1093/carcin/bgag065
BibTeX
@article{Guo2026,
author = {Guo, Biao and Liang, Yiyi and Qin, Xiaofeng and Yang, Zile and Yu, Jiahui and Liu, Ruoyun and Ma, Yijing and Zheng, Qidan and Ye, Xiyun and Dang, Yongyan},
title = {GPR87 promotes DMBA/TPA-induced skin tumorigenesis through the YAP–SOX2 axis},
journal = {Carcinogenesis},
year = {2026},
doi = {10.1093/carcin/bgag065}
}
EUVIMED